喘作为风险因素和过敏性鼻炎作为COVID-19严重程度的保护因素:一个病例控制研究
Martha Débora Lira Tenório1,2, Gabriel Valentim Dos Santos Menezes Siqueira3, Gustavo Costa Caldas3
1Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, SE, Brazil.
喘增加了严重的COVID-19风险,而鼻炎似乎可以保护未接种疫苗的成年人免受严重的后果. 这些发现突出了呼吸道过敏对COVID-19严重性的不同影响.
科学领域:
- 医学研究 医学研究
- 流行病学 流行病学
- 肺部病理学 肺部病理学
背景情况:
- 在全球范围内,COVID-19疫情造成了显著的发病率和死亡率.
- 潜在的并发症影响COVID-19的临床谱.
- 喘和过敏性鼻炎在COVID-19严重性中的作用受到争论.
研究的目的:
- 调查喘,过敏性鼻炎和COVID-19严重程度之间的联系.
- 在广泛部署疫苗之前,专注于未接种疫苗的成年患者.
- 分析特定地理区域的数据.
主要方法:
- 这是一项对122名未接种疫苗的COVID-19患者的病例控制研究.
- 病例:严重/危急的COVID-19需要ICU入院.
- 对照组:非严重的COVID-19没有肺炎或缺氧.
- 使用ISAAC问卷评估了喘和鼻炎.
- 多变量逻辑回归分析了关联.
主要成果:
- 喘与严重COVID-19的可能性增加相关 (OR=13.0).
- 鼻炎与严重后果的保护作用相关 (OR=0.36).
- 在喘发作频率或鼻炎严重程度方面没有发现显著的关联.
结论:
- 喘与更高的严重COVID-19风险相关;鼻炎可能具有保护性.
- 这些发现澄清了呼吸道过敏和COVID-19之间的复杂相互作用.
- 强调需要有针对性的临床管理和公共卫生战略.
更多相关视频
11:54Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
09:58A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
相关概念视频
Asthma-I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
